NextPlat NXPL
NASDAQ NXPL
$9.00 -0.20 (-2.15%)
As of: Sep 29, 2026 · 3:58 PM EDT

NextPlat (NXPL) Research & Development (2011 - 2013)

Updated

NextPlat (NXPL) recorded Research & Development of $115,832 in FY2012, down 25.9% from $156,363 in FY2011.

Analysis

NextPlat (NXPL) Research & Development (2011 - 2013) Analysis & Trends

  • Per Business Quant data, NXPL's Research & Development was $156,363 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 NextPlat 24.55 Mn -25.93 Mn 4.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 5,000.00
Sep 30, 2012 43,165.00
Jun 30, 2012 29,587.00
Mar 31, 2012 10,949.00
Dec 31, 2011 31,451.00
Sep 30, 2011 63,292.00
Jun 30, 2011 61,620.00
API Access

NextPlat Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=NXPL&period=max&api_key=YOUR_API_KEY